.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Colorcon
Novartis
Farmers Insurance
UBS
McKinsey
Deloitte
Harvard Business School
Moodys
Cerilliant

Generated: November 24, 2017

DrugPatentWatch Database Preview

Drug Master Files for: Yung Shin Pharm

« Back to Dashboard

DMF No. Status Type Submission Date Holder Subject
9121III4/30/1991YUNG SHIN PHARMACEUTICAL INDUSTRIES CO LTDMANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN TAIWAN, CHINA.
14048III3/29/1999YUNG SHIN PHARMACEUTICAL INDUSTRIES CO LTDMANUFACTURING FACILITY IN TAIWAN, CHINA FOR THE PRODUCTION OF LOVASTATIN
14049III3/29/1999YUNG SHIN PHARMACEUTICAL INDUSTRIES CO LTDLOVASTATIN
15319AII2/23/2001YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDPACLITAXEL
15447III5/15/2001YUNG SHIN PHARMACEUTICAL INDUSTRIES CO LTDPANCRELIPASE CR PELLETS
22795AII3/23/2009YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDMECLOFENAMATE SODIUM
23872III6/10/2010YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDCEPHALEXIN USP YUNG SHIN
26651AII12/26/2012YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDZOLEDRONIC ACID
26652AII12/26/2012YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDDOCETAXEL TRIHYDRATE
27600AII2/26/2014YUNG SHIN PHARMACEUTICAL INDUSTRIAL CO LTDENTECAVIR MONOHYDRATE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
US Department of Justice
Harvard Business School
Farmers Insurance
Covington
Baxter
Dow
US Army
Moodys
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot